AlphaYouCTSO: Capponi Vincent discloses a purchase
By AlphaYouPublished Form 4
Capponi Vincent
Reporting filer
Capponi Vincent reported Purchase in Cytosorbents Corp: 1800 units of Common Stock, dated 2026-09-14. The full Form 4 contains 2 transaction entries.
- Disclosed
- Sep 16, 2026
Reported details
2 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Capponi Vincent | 2026-09-14 | P | Purchase | 1800 | 6.07 | 40,114 | 2 days | Filed terms
|
| Common Stock | Capponi Vincent | 2026-09-14 | P | Purchase | 273 | 5.90 | 40,387 | 2 days | Filed terms
|
Common Stock
- Owner
- Capponi Vincent
- Date
- 2026-09-14
- Code
- P
- Action
- Purchase
- Quantity
- 1800
- Price
- 6.07
- Following holdings
- 40,114
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-09-14
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: P
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 1800
- id: F1
- transaction Price Per Share: 6.07
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 40114
- id: F2
- id: F3
- id: F4
- id: F5
- direct Or Indirect Ownership: D
Common Stock
- Owner
- Capponi Vincent
- Date
- 2026-09-14
- Code
- P
- Action
- Purchase
- Quantity
- 273
- Price
- 5.90
- Following holdings
- 40,387
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-09-14
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: P
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 273
- id: F1
- transaction Price Per Share: 5.90
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 40387
- id: F2
- id: F3
- id: F4
- id: F5
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Capponi Vincent: President and COO.
- F1: This transaction reported on this Form 4 reflects an open market purchase made by the Reporting Person.
- F2: Includes: (i) the following RSUs that will be settled into Common Stock upon vesting upon a "Change In Control" of CytoSorbents Corporation (the "Issuer") as defined in the Amended and Restated CytoSorbents Corporation 2014 Long-Term Incentive Plan (the "Plan"): (a) 505 RSUs granted on March 15, 2018, (b) 895 RSUs granted on February 24, 2017, (c) 2,700 RSUs granted on June 7, 2016 and (d) 6,250 RSUs granted on April 8, 2015;
- F3: (continued from footnote 2) (ii) the following RSUs, which vest in equal parts on the first year anniversary of the date of grant and the second year anniversary of the date of grant, subject to the Reporting Person's continued service as of the applicable vesting date, and will settle into shares of Common Stock of the Company upon vesting: 4,455 RSUs granted on August 8, 2025 and of which 2,228 remain unvested as of the date hereof; and
- F4: (continued from footnote 3) (iii) 25,736 shares of Common Stock owned by the Reporting Person.
- F5: Reflects the 1-for-20 reverse stock split effected by the Issuer on September 8, 2026.
Original sources
Prepared automatically from public filing data. Report a correction.